Electrotransfer (electroporation) is recognized as one of the most promising alternatives to viral vectors for transfection of different tissues in vivo for therapeutic purposes. We evaluated the transfection efficiency of reporter genes (green fluorescent protein and luciferase) in murine subcutaneous tumors using different combinations of high-field (HV) (600-1400 V cm À1 , 100 ms, 8 pulses) and low-field (LV) (80-160 V cm À1 , 50-400 ms, 1-8 pulses) pulses and compared it to protocol using eight identical pulses of 600 V cm À1 and 5 ms duration (electro-gene therapy, EGT). Expression of GFP was determined using a fluorescent microscope and flow cytometry and expression of luciferase by measuring its activity using a luminometer. The EGT protocol yielded the highest expression of both reporter genes. However, a careful optimization of combinations of HV and LV pulses may result in similar transfection as EGT pulses. With the combination protocol, relatively high fields of LV pulses were necessary to obtain comparable transfection to the EGT protocol. Expression of reporter genes was higher in B16 melanoma than in SA-1 fibrosarcoma. Our data support the hypothesis that both electropermeabilization and electrophoresis are involved in electrotransfer of plasmid DNA, but demonstrate that these components have to happen at the same time to obtain significant expression of the target gene in tumors.
Introduction
Since its discovery in 1982 by Neumann et al., transfer and expression of foreign DNA by electropulsation (electroporation) into mammalian cells in vitro and in vivo has been the focus of growing research interest. 1, 2 It is now recognized as one of the most promising alternatives to viral vectors for transfection of different tissues in vivo for therapeutic purposes. [3] [4] [5] Gene therapy using electropulsation as a gene delivery method has already entered clinical trials for the treatment of different tumor types in cancer patients and for vaccination. [6] [7] [8] [9] Electrotransfer of plasmid DNA has been assayed and used in many different tissues, such as skin, muscle, liver, tumors, lung, cornea, kidney, brain, cartilage, bladder, carotid artery and tendon. [6] [7] [8] However, most studies were carried out in muscle, where high transfection efficiencies can be obtained. So far, the transfection efficiencies obtained in tumors following electropulsation have been smaller compared to other tissues, [10] [11] [12] but a significant therapeutic effect can nevertheless be obtained by electrotransfer of therapeutic genes into tumors. 7, 8 Classically, electrically mediated gene delivery is obtained by submitting the target to a train of pulses lasting a few milliseconds or 100 microseconds at a 1 Hz frequency, and adjusting the voltage to the electrode width. [10] [11] [12] [13] [14] [15] [16] A new protocol with high transfection efficacy in muscle and skin has recently been described, consisting of a combination of one high-field (HV, B1000 V cm À1 ) and one (or several) low-field (LV, B100 V cm À1 ) pulse. [17] [18] [19] [20] [21] [22] [23] For simplicity, we called all along the paper 'field' what indeed is the voltage to electrode width ratio, that is, an experimentally controlled parameter. In these studies, the authors suggested two functions of these electric pulses. The 'HV' pulse permeabilizes the cells, whereas the 'LV' pulse drives plasmid DNA toward the cells and against the permeabilized membrane by the associated electrophoretic force. 19 In this new methodology, both types of pulses are necessary for successful gene expression in target cells, as described in the literature. The number of 'LV' pulses can vary, provided the overall duration of the pulses is kept constant. 19 The amplitude of efficient 'HV' and 'LV' pulses differs between muscle and skin, which might be attributed to the morphological and histological differences between these two tissues. Conditions used for skin transfection are known to be damaging for muscles. Field effects are dependent on cell shape and size, the orientation of the cells versus the field orientation and the composition of the tissue. [24] [25] [26] Nevertheless, it has been suggested that the function of 'HV' and 'LV' pulses is the same for both tissues, the 'HV' pulse permeabilizes target cells and the 'LV' pulse electrophoretically transports the DNA to the cells.
Some other studies have demonstrated that DNA electrophoresis might not be so important in electrotransfer of plasmid DNA into cells and that effective gene transfer is associated with cell membrane permeabilization and passive diffusion. 27 However, it has been demonstrated in tumors that passive transport is ineffective for transfection of cells although in the case of uncharged macromolecules of a similar size to that of plasmid DNA, convection has been suggested to have a major function in the cellular uptake of these molecules. 28 To date, only one study has used a combination of HV and LV pulses for electrotransfer of granulocyte-monocyte colony-stimulating factor and B7-1 plasmid into solid subcutaneous tumors for gene-based immunotherapy. 29 However, systematic analysis of the transfection efficiencies of protocols combining HV and LV pulses in tumors has not yet been done. The aim of our study was therefore to investigate whether the application of HV and LV pulses would result in effective transfection efficiency in tumors. For this purpose, different combinations of 'HV' and 'LV' pulses were compared to the 'standard' electro-gene therapy (EGT) protocol using identical pulses of 600 V cm À1 and 5 ms duration. These are currently used by our group, but of course are not necessarily accepted as standard pulses by other investigators in this field.
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Results
Electropermeabilization of cells in tumors
To determine whether a combination of HV and LV pulses induces permeabilization of the cell membrane in B16 tumors in vivo, tumors were injected with propidium iodide (PI) and electropulsated. Strong fluorescence was observed in the periphery of the tumors. The highest percentage of permeabilized cells, with the highest mean fluorescence intensity of permeabilized cells, was obtained in tumors that were exposed to EGT pulses.
Furthermore, the percentage of permeabilized cells was statistically significantly higher in tumors that were exposed to EGT pulses and a combination of 1 HV+8 LV pulses compared to the control. A high background in fluorescence was present in the control. The level of permeabilization of tumor cells did not significantly differ between control tumors and tumors that were exposed to either LV pulses alone or one HV pulse alone, indicating that LV pulses and 1 HV pulse alone do not cause a detectable electropermeabilization of cell membranes in tumors (Figure 1) .
A relatively high level of PI in nonelectropulsated tumors indicated a high percentage of dead cells within these tumors. However, the mean fluorescence intensity tended to be higher in tumors that were exposed to electric pulses compared to untreated tumors, indicating that higher amounts of PI entered the cells of electropulsated tumors (Figure 1 ). It should be kept in mind that although easy to perform on living animals, the PI assay is lacking in sensitivity, which might be due to tissue organization, as we have shown with cell pellets. 30 
Transfection efficiency
To determine the transfection efficiency of different protocols using combinations of HV and LV pulses, plasmid encoding luciferase was used. The level of luciferase expression of these protocols was compared to the level of luciferase expression of the 'standard' electrotransfer protocol used in our laboratories (EGT pulses, 8 Â 5 ms pulses) and to electric pulses used for electrochemotherapy protocols (ECT pulses, 8 Â 0.1 ms HV pulses). Measurement of luciferase activity is a relatively simple and quick method of determining the level of gene expression; however, it does not give information about the spatial distribution of transfection in tumors, which can be obtained with the use of green fluorescent protein (GFP). In the first part of the study, therefore, luciferase activity was used as a measure of the level of gene expression and a detailed analysis of the selected pulse parameters was later carried out using GFP expression. The level of luciferase expression of the combination of HV and LV pulses with regard to the amplitude of the HV pulse and the time lag between HV and LV pulses was first determined in two tumor models, B16 melanoma and SA-1 fibrosarcoma and compared to EGT and ECT pulses. The 'standard' EGT protocol using eight identical pulses of 600 V cm À1 and 5 ms duration yielded significantly higher luciferase activity in both tumor models compared to all other electropulsation protocols ( Figure 2 ).
The amplitude of the HV pulses had a minor influence on the level of luciferase expression. In B16 tumors, a plateau in the level of luciferase activity was obtained at 800 V cm À1 or higher but this was not statistically significant (Figures 2a and c) . In SA-1 tumors, the level of luciferase expression did not differ regarding increasing HV amplitude (Figures 2c and d) . Furthermore, the time lag between the HV and LV pulses did not affect the expression of luciferase, so in the subsequent experiments, HV and LV pulses were applied without any time lag between them. In general, luciferase activity was B2 times higher in B16 tumors than in SA-1 tumors. This appears to be due to their histological properties. 26 Luciferase activity in tumors as a function of LV pulse amplitude, number and duration
In the second set of experiments, different amplitudes, numbers and durations of LV pulses were tested, keeping the total time of the application constant (400 ms). HV pulse amplitude was set to 1200 V cm
À1
and LV pulses were applied immediately after the HV pulse (no time lag).
In both tumor models, the increase in amplitude of the applied LV pulses resulted in an improved level of luciferase expression. In B16 tumors, the combination of 1 HV pulse and 4 LV 100 ms pulses of 140 V cm À1 or 1 HV pulse with 8 LV 50 ms pulses of 160 V cm À1 resulted in a luciferase activity close to the 'standard' electro- In the SA-1 tumor model, only the combination of 1 HV and 8 LV 50 ms pulses above 140 V cm À1 resulted in the same luciferase activity as the EGT pulses, whereas the level of luciferase expression of all other combinations of 1 HV and 4 LV pulses was significantly lower and within the range of the level of luciferase expression that was obtained with the electrochemotherapy protocol (ECT pulses) (Figures 3c and d) . The level of luciferase expression using 8 LV 50 ms pulses alone (140 V cm À1 ), which was used as a control, was much lower than a combination of 1 HV and 8 LV of the same amplitude (Figures 3b and d) .
Luciferase activity in tumors as a function of the number of HV pulses
To test whether the better permeabilization of tumor cells, which is obtained by a larger numbers of HV pulses, would result in an increased level of luciferase expression, different number of HV electric pulses were combined with 8 LV 50 ms pulses of 120 V cm
À1
. This strategy did not significantly affect the level of luciferase expression, either in B16 or in SA-1 tumors (Figures 4a  and b) . In B16 tumors, the level of luciferase expression using this electropulsation protocol was the same as with the use of EGT pulses. In contrast, the level of luciferase expression was significantly lower in SA-1 tumors compared to the level of luciferase expression obtained by the 'standard' electropulsation protocol, that is, EGT pulses.
GFP expression in tumors
Further experiments were performed with selected conditions using GFP as a reporter gene to analyze the spatial distribution of transfection in B16 tumors. The visualization in vivo across the skin of anesthetized mice was not as successful as expected, due to the low level of Electrotransfer of tumors M Cemazar et al electrotransfection in tumors. [10] [11] [12] No time lapse followup on the same animal was thus possible. The mice were therefore killed by cervical dislocation 48 h after electropulsation and the tumors were removed and split in half. GFP expression was evaluated under fluorescence stereomicroscope. GFP expression was observed mainly in the periphery of the tumor. Higher GFP expression was observed in the tumors treated with the 'standard' EGT pulses ( Figure 5 ).
The precise location of GFP expression was determined on frozen tumor sections. The GFP expression, as already observed in tumor halves, was mainly located at the periphery of the tumor section. In the tumors that were treated with 'standard' EGT pulses, the expression of GFP was more scattered over all tumor sections than with the HV LV protocols. This perhaps suggests that more cells were transfected within the tumors ( Figure 6 ).
In addition, tumors were also processed for flow cytometry analysis after dissociation, to determine the number of transfected tumor cells. The highest percentage of tumor cells expressing GFP was B5%, which was obtained by 'standard' EGT pulses. This percentage was statistically significantly different from the other groups ( Figure 7) . Furthermore, the mean fluorescence intensity at LV pulse amplitude 100 V cm À1 was in the same range for all tested electropulsation protocols, indicating that approximately the same amount of plasmid DNA coding for GFP was expressed in the electrotransfected cells ( Figure 7) .
Discussion
There are numerous factors that influence the transfection efficiency of gene electrotransfer in tumors. They can be divided into three categories: parameters of electric pulses, construction of plasmid and histological characteristics of tumors. 4, 5 By careful and specific selection of these factors, DNA distribution in the tumors, distribution of electric field affecting permeabilization and expression of therapeutic gene can be controlled and adjusted to specific gene therapy. In our study, the focus was on the influence of electric parameters for electrotransfection, with the aim of investigating whether the application of HV and LV pulses would result in effective transfection in tumors and also to test the hypothesis that the electrophoretic force is crucial (is the mechanism responsible) for transfection of tumors in vivo.
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Several aspects of HV and LV combination were evaluated in our study. First, the time lag between the HV and LV pulses was tested. To minimize the unpleasant sensation caused by muscle contractions during the application of electric pulses, there should be no time lag between HV and LV pulses. 32 We demonstrated that the time lag did not influence transfection efficiency in tumors. In addition to time lag, an increase in the amplitude of the HV pulse combined with 1 LV pulse was evaluated. The increase of HV amplitude did not result in an increase of transfection, indicating that cells within the tumor were already permeabilized at 600 V cm
À1
. However, in this set of experiments, the transfection efficiency with a combination 1 HV and 1 LV was very low compared to 'standard' EGT pulses. Further experiments were therefore performed to evaluate the different number and amplitudes of LV pulses. Experiments in muscle suggested that transfection efficiency should be approximately the same, if the total duration and field strength for LV pulses did not differ between the protocols. 19 Nevertheless, recent results have indicated that a higher number of LV pulses result in better transfection effectiveness in muscle. 22 Our present results clearly demonstrated that 1 HV and 8 LV electric pulses resulted in significantly higher transfection efficiency in tumors than smaller numbers of LV pulses. In addition, a relatively high amplitude of LV pulses was required to obtain transfection, presumably due to the heterogeneity of the tumors in terms of cell shape, orientation, density and extracellular matrix content. It has to be taken into account that with plate electrodes, a 
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homogeneous field is present within the tumor but its amplitude is low due to the insulating properties of the skin. 33, 34 Another important finding of our study is that neither LV pulses alone nor HV pulses alone resulted in substantial permeabilization and transfection of This result supports studies performed in muscles demonstrating that both electropermeabilization and electrophoresis were crucial for effective transfection. 19 However, the high density of cells within a tumor might be the reason for the lack of detection of permeabilization (and as a result of transfection), as we observed in the case of cell pellets. 35 The results of present study demonstrated in both tumors that relatively high fields of LV pulses (about 140 V cm À1 ) are necessary to obtain transfection. This high field is lower than that used for skin (200 V cm À1 ), but much higher than that used in the combination protocol for muscle (80-100 V cm À1 ). 18 The differences in transfection efficiency between different tissues, as well as different tumor histological types, can be explained by the unique characteristics of each tissue, 5, 26 namely, the delivery and distribution of macromolecules, including plasmid DNA, is affected by the amount of DNases, necrosis and macrophage infiltration as well as increased interstitial fluid pressure and the amount of extracellular matrix components, such as collagen and hyaluronan. In addition, in vitro and in vivo studies have elucidated the effect of the shape, size and orientation of cells in tissue and cell density on electric field distribution, which are all crucial factors for effective electrotransfection. 24, 26, 30 We pointed out in a recent study 26 that the histological properties of tumors are responsible for different transfection efficiencies obtained and this may also be true for the different transfection efficiencies obtained in different tissues using the same electric pulse parameters.
However, comparison of our results of HV LV combination pulses to EGT pulses in tumors in other tissues indicates that the separation of electropermeabilization and electrophoretic components of HV and LV pulses in tumors does not result in better transfection efficiency. Our study shows that in both tumor models, the 'standard' EGT protocol yielded the highest expression of both reporter genes, luciferase and GFP. However, carefully optimized combinations of HV and LV pulses can result in a comparable level of luciferase expression with the 'standard' protocol (EGT pulses), using luciferase assay. Nevertheless, measurement of GFP-positive cells by flow cytometry showed that EGT pulses were more efficient and yielded the highest number of fluorescent cells compared to other groups ( Figure 7 ). However, it should be taken into account that these experiments were performed at optimal LV pulse of 140 V cm À1 or above. Our results demonstrate that transfection occurred only in tumors in which permeabilization of the cell membrane also occurred. These results are supported by a recent study of Henshaw et al., 36 which measured electric-field-mediated interstitial transport in 4T1 and B16F10 tumors implanted in mouse dorsal skin-fold chamber. The results revealed that the largest distance of plasmid DNA transport was obtained at 400 V cm À1 and 50 ms pulse (10 pulses), with distances of 0.22 and 0.23 mm per pulse. This meant that interstitial transport of DNA induced by pulses is ineffective for macroscopic delivery of genes in tumors. However, they demonstrated that induced transport was more effective than passive diffusion. 36 Plasmid DNA has therefore to be present close to or in contact with the cell membrane to interact and pass into the cell. Electric pulses act at a microscopic level by pushing DNA toward the membrane during electropermeabilization. So 'standard' EGT pulses that have both components present at the same time (permeabilization and electrophoresis) yielded a higher transfection efficiency compared to a combination of HV and LV pulses, in which the components are separated.
In conclusion, our study provides a detailed evaluation of different HV and LV electropulsation protocols for effective transfection of tumors. Compared to results in relation to other tissues, this treatment protocol does not lead to better transfection efficiency or increased convenience or safety of the procedure. Our data support the hypothesis that both electropermeabilization and electrophoresis are involved in electrotransfer of plasmid DNA, but demonstrate that these components have to happen at the same time to obtain significant expression of the target gene.
Materials and methods
Experimental animals, cell lines and tumor types
Animal studies were carried out according to the guidelines of the Ministry of Agriculture, Forestry At the beginning of the treatment, the animals were randomly divided into experimental groups and subjected to specific experimental protocols. The number of animals in experimental groups was from 3 to 18.
Plasmids
Plasmid construct pEGFP-C1 (Clonetech, Palo Alto, CA, USA) carrying the gene of GFP and pCMVLuc (encoding luciferase, kind gift from Dr Lluis M Mir, Institute Gustave Roussy, France), both controlled by an efficient promoter (cytomegalovirus) were used. They were prepared from transfected Escherichia coli cells by using an EndoFree Plasmid Maxi kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions and diluted in H 2 O to a concentration of 1 mg ml
Intratumoral DNA injection and electric pulse delivery Animals were kept under isoflurane/air anesthesia during the whole procedure. Fifty microliters of plasmid (50 mg) in saline buffer was injected directly into the tumor using a 25-gauge needle on a 1 ml syringe (Terumo Europe, Leuven, Belgium). Two days before electropulsation, the hair above the tumor was removed by using a hair removal cream (Veet, Reckitt Benckiser, Slough, UK). Electric pulses were applied within 1 min after injection, the electrodes being brought into contact with the skin around the injection point. Plate parallel electrodes (IGEA, Carpi, Italy) were used. The distance between the electrodes was 6 mm. Conducting paste (Comepa, St Denis, France) was used to ensure good electrical contact between the electrodes and the skin surface. Different electropulsation protocols were compared. Two electropulsation protocols were composed of trains of identical pulses (EGT pulses: 8 Â 5 ms, 600 V cm À1 , 1 Hz; ECT pulses: 8 Â 0.1 ms, 1300 V cm À1 , 1 Hz) and the other electropulsation protocols were composed of different 'HV' and 'LV' pulses of different amplitudes and duration. The exact parameters of the applied 'HV' and 'LV' pulses are described in the Results section. Electric pulses for the EGT and ECT protocols were generated by a Jouan electropulsator (Jouan, St Herblain, France) and the electric pulses used in other electropulsation protocols by Cliniporator (IGEA). The same set of electrodes was used with both electropulsators. Online monitoring of the pulse delivery was always carried out.
Assessment of permeabilization of cells in tumor
Tumors were injected with 50 ml 0.5 mM PI and exposed to electric pulses immediately thereafter. The injection protocol was same as for plasmids. Mice were killed 2 h after treatment by cervical dislocation. The tumors were removed and split in half and the fluorescence intensity was evaluated under fluorescence stereomicroscope (Leica MZFLIII, Germany). After visualization, the tumors were placed in phosphate-buffered saline (PBS) and mechanically dissociated. Aggregates were removed by filtration and the tumor cells were washed once in PBS. Quantification of cells stained by PI was evaluated by flow cytometry (FACScan; Becton Dickinson, San Jose, CA, USA).
Assessment of luciferase activity
Tumors treated with plasmid pCMVLuc were weighed, immediately frozen in liquid nitrogen and stored at À80 1C until further procedures. Thawed tumors were homogenized in 1 ml of Glo Lysis Reagent (Promega, Madison, WI, USA) using a sonificator UP200H (Dr Hielscher, Teltow, Germany). Thereafter, the samples were centrifuged at 10 000 g for 10 min and the supernatant was stored at À80 1C. Luciferase activity was measured in thawed supernatants using a Genios luminometer (Tecan, Zurich, Switzerland). Photoemission was measured during a 5 s period after 5 min incubation at room temperature of 100 ml tumor cell lysate and 100 ml Luciferase Assay Substrate (Promega). Luciferase activity was quantified as relative light units and then converted to pg luciferase per mg tumor tissue, using the pre-prepared calibration curve of known quantities of luciferase (Promega). Transfection efficiency and spatial distribution of GFP were estimated in frozen tumor sections using fluorescence microscope BX51 equipped with a DP70 CCD camera (Olympus, Hamburg, Germany).
Statistical analysis
The data were tested for normality of distribution using the Kolmogorov-Smirnov test. Differences between experimental groups were statistically evaluated by one-way analysis of variance followed by the HolmSidak test for multiple comparison. A P-value of less than 0.05 was considered to be statistically significant. Statistical analysis was carried out using SigmaStat (Systat Software Inc., San Jose, CA, USA) software.
